Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02430428 · ClinicalTrials.gov registry record · NA
Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser
A NA study of Myopia and Astigmatism, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- NA
- Development phase
- 357
- Enrollment target
- 5
- Study locations
NCT02430428 is a NA study of Myopia and Astigmatism that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 357 participants, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (35% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT02430428, a NA study of Myopia and Astigmatism, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- NA
- Development phase
- 357 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or elimination of myopia from ≥ -1.00 D to ≤ -10.00 D with ≤ -3.00 D cylinder (myopia with or without astigmatism) and MRSE ≤ -11.50 D.
Conditions Studied
Interventions
- DEVICE Carl Zeiss Meditec VisuMax Femtosecond Laser
Study Locations (5)
Colorado
- Dishler Laser Institute - Greenwood Village
Kansas
- Discover Vision Centers - Leawood
South Dakota
- Vance Thompson Vision - Sioux Falls
Texas
- Slade and Baker Vision Center - Houston
Wisconsin
- Davis Duehr Dean - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02430428
The ClinicalTrials.gov registry entry for NCT02430428 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 357 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (35% higher). The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Carl Zeiss Meditec VisuMax Femtosecond Laser is the first listed.
NCT02430428 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Colorado, Kansas, South Dakota.
Frequently Asked Questions
What is clinical trial NCT02430428 about?
NCT02430428 is a clinical study titled "Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser". The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or elimination of myopia from ≥ -1.00 D to ≤ -10.00 D with ≤ -3.00 D cylinder (myopia with or without astigmatism) and M...
What is the current status of trial NCT02430428?
This trial is currently completed. It is a NA study. The enrollment target is 357 participants. The study started on 2015-03. Estimated completion is 2017-10.
What conditions does trial NCT02430428 study?
This clinical trial studies the following conditions: Myopia, Astigmatism.
What interventions are being tested in trial NCT02430428?
The interventions under investigation include: Carl Zeiss Meditec VisuMax Femtosecond Laser (DEVICE).
Who is sponsoring clinical trial NCT02430428?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02430428 being conducted?
This trial has 5 study locations across Colorado, Kansas, South Dakota, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.